[HTML][HTML] Novel insights and new therapeutic potentials for macrophages in pulmonary hypertension

Y Zuo, B Li, M Gao, R Xiong, R He, N Li, Q Geng - Respiratory Research, 2024 - Springer
Inflammation and immune processes underlie pulmonary hypertension progression. Two
main different activated phenotypes of macrophages, classically activated M1 macrophages …

Mendelian Randomization in Pulmonary Arterial Hypertension: Unveiling Early Insights With Promise for Future Discoveries

S Provencher, BJ Arsenault… - Journal of the American …, 2024 - Am Heart Assoc
Pulmonary arterial hypertension (PAH) is a complex condition characterized by the gradual
restructuring of the distal pulmonary arteries, culminating in right ventricular failure and …

[HTML][HTML] Assessing the correlation between the degree of tricuspid regurgitation and pulmonary hypertension: A comprehensive study

JS AlRahimi, YM Ismail, NA Aljubairi… - Saudi Medical …, 2024 - ncbi.nlm.nih.gov
Objectives: To evaluate the relationship between severity of tricuspid regurgitation (TR) and
pulmonary hypertension. Methods: Cross-sectional study of 118 patients with pulmonary …

Serum metabolite changes are implicated in high-altitude acclimatization and de-acclimatization

W Wei, X Liu, W Yang, Q Li, M Cai, W Dai, H Zhang… - 2024 - researchsquare.com
For individuals from lowland areas traveling to high-altitude regions, acclimatization and de-
acclimatization (ADA) to high altitudes is an inevitable physiological process, accompanied …

Investigating the Therapeutic Utility of Human Amniotic Epithelial Cell-derived Exosomes in Pulmonary Arterial Hypertension

PC Wang - 2024 - bridges.monash.edu
Pulmonary hypertension (high blood pressure in the lungs), is an incurable and often fatal
disease. It is more prevalent in females yet more severe in males. Existing drugs provide …